Loading...
Loading...
PCRX| Name | Value |
|---|---|
| Revenues | 187.3M |
| Cost of Revenue | 39.9M |
| Gross Profit | 147.4M |
| Operating Expense | 122.7M |
| Operating I/L | 24.7M |
| Other Income/Expense | 0.8M |
| Interest Income | 5.6M |
| Pretax | 25.5M |
| Income Tax Expense | 9.5M |
| Net Income/Loss | 16.0M |
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions in the United States. The company's flagship products include EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used for targeted nerve treatment. Additionally, Pacira BioSciences develops proprietary multivesicular liposome drug delivery technology, encapsulating drugs without altering their molecular structure.
